Information Library
Results for: Oncology - Faster product development - Central Laboratories
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer
White Paper — June 23, 2011
In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. -
Translational R&D Services Fact Sheet
Brochure — May 26, 2011
Quintiles’ Translational R&D Center of Excellence performs groundbreaking research and offers novel findings in oncology for biopharmaceutical companies. -
Clinical – Smarter Trials, Accelerated Outcomes
Brochure — February 16, 2011
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
BIOMODA SELECTS QUINTILES TO HELP DEVELOP MORE ACCURATE AUTOMATED SYSTEM FOR DETECTING EARLY-STAGE LUNG CANCER
Press Release — November 15, 2010 – Cancer diagnostics company Biomoda, Inc. has allied with Quintiles' Central Laboratories to help refine the automated image recognition system for measuring the photon emission rate and cell morphology of CyPath®-stained cells to detect early stage lung cancer.
-
DAKO AND QUINTILES FORM ALLIANCE TO SPEED DEVELOPMENT OF PERSONALIZED MEDICINE
Press Release — November 1, 2010 - Dako and Quintiles announced a strategic alliance to advance personalized medicine by collaborating on the co-development of targeted therapies and companion diagnostics.
-
Podcast: Clinical Development of Cancer Drugs in China
Hear from the Experts — October 18, 2010
Hear exclusive interviews with Quintiles's experts, Christopher Ung, Patty James and Harish Dave on their recent participation at the 13th Annual Chinese Society of Clinical Oncology -
QUINTILES ANNOUNCES SUITE OF PI3K BIOMARKER ASSAYS TO ADVANCE ONCOLOGY THERAPIES TARGETING THIS CANCER PATHWAY
Press Release — June 7, 2010 - Suite is part of Quintiles Global Central Labs’ ongoing efforts to advance personalized medicine.
-
Biomarker Trends in Breast Cancer Research
White Paper — February 24, 2010
Dr. Hill discusses the implications and questions that will drive future R&D efforts to develop targeted breast cancer therapies. -
Tissue Biomarkers in Oncology Clinical Development: The Digital Advantage
Presentation — September 15, 2009
The advantages of incorporating digital pathology into your oncology clinical development process. -
Validated Biomarker Menu
Brochure — July 14, 2009
A comprehensive menu of validated cell, fluid and tissue based biomarker assays.
